Cargando…
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
A prospective, multicentre, phase IIIb study with an exploratory, open-label design was conducted to evaluate efficacy and safety of anidulafungin for the treatment of candidaemia/invasive candidiasis (C/IC) in specific ICU patient populations. Adult ICU patients with confirmed C/IC meeting ≥1 of th...
Autores principales: | Ruhnke, M, Paiva, J A, Meersseman, W, Pachl, J, Grigoras, I, Sganga, G, Menichetti, F, Montravers, P, Auzinger, G, Dimopoulos, G, Borges Sá, M, Miller, P J, Marček, T, Kantecki, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510306/ https://www.ncbi.nlm.nih.gov/pubmed/22404732 http://dx.doi.org/10.1111/j.1469-0691.2012.03784.x |
Ejemplares similares
-
Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
por: Ruhnke, M, et al.
Publicado: (2011) -
Cost-effectiveness analysis of anidulafungin in the treatment of candidaemia
por: Auzinger, G, et al.
Publicado: (2013) -
Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis
por: Auzinger, Georg, et al.
Publicado: (2015) -
Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study)
por: Ramos, Jose Tomas, et al.
Publicado: (2017) -
Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial
por: Mylonakis, Eleftherios, et al.
Publicado: (2018)